Please use this identifier to cite or link to this item:
https://doi.org/10.1089/tmj.2012.0136
Title: | Feasibility and acceptance of a pharmacist-run Tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients | Authors: | Yap, K.Y.-L. Low, H.X. Koh, K.S. Un, M. Shih, V. Chan, A. |
Keywords: | ambulatory cancer patients chemotherapy-induced nausea and vomiting oncology pharmacist-run tele-oncology service post-chemotherapy symptom management short message service technology side effect telemonitoring |
Issue Date: | 1-May-2013 | Citation: | Yap, K.Y.-L., Low, H.X., Koh, K.S., Un, M., Shih, V., Chan, A. (2013-05-01). Feasibility and acceptance of a pharmacist-run Tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients. Telemedicine and e-Health 19 (5) : 387-395. ScholarBank@NUS Repository. https://doi.org/10.1089/tmj.2012.0136 | Abstract: | Background: The use of telemedicine for cancer patients is limited, particularly in Asia. These patients need to be monitored because more are being treated as outpatients, so that any treatment-related side effects can be managed. We assessed the feasibility and acceptance of a pharmacist-run tele-oncology service to monitor chemotherapy-induced nausea and vomiting (CINV) in ambulatory cancer patients. Patients and Methods: A single-center, prospective study was conducted at a local cancer center. Patients' CINV symptoms were monitored through short message service (SMS) for 5 days post-chemotherapy. Feasibility was measured by patients' adherence to the service, patient satisfaction, and number of pharmacist interventions. Acceptance was measured by the accrual rate. Results: The accrual rate was 37.6% (68/181 patients). Sixty patients (median age, 49.5 years) completed the study. Overall adherence was 73.3%. The majority (90.0%) were comfortable with the duration of SMS monitoring, especially adherent patients (95.5% versus 75.0%, p=0.038). Over half (61.7%) found the SMS advice useful. Twenty-two intervention calls were made by pharmacists for uncontrolled CINV. Conclusions: A pharmacist-run tele-oncology service for real-time monitoring of CINV is feasible in ambulatory cancer patients. Incorporating the monitoring of other side effects will enhance its value and acceptance by patients for post-chemotherapy symptom management. © 2013, Mary Ann Liebert, Inc. 2013. | Source Title: | Telemedicine and e-Health | URI: | http://scholarbank.nus.edu.sg/handle/10635/105957 | ISSN: | 15305627 | DOI: | 10.1089/tmj.2012.0136 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.